Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Philips completes the acquisition of BioTelemetry, Inc.
Royal PhilipsFebruary 9, 2021 GMT February 9, 2021
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it has completed the acquisition of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring. BioTelemetry’s financial results will be consolidated as part of Philips’ Connected Care business segment as of February 9, 2021.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Philips successfully completes tender offer for BioTelemetry, Inc.
Royal PhilipsFebruary 9, 2021 GMT February 9, 2021
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has successfully completed its previously announced tender offer (the “Offer”) to purchase all outstanding shares of BioTelemetry, Inc. (NASDAQ: BEAT), a leading U.S.-based provider of remote cardiac diagnostics and monitoring for USD 72.00 per share in cash. At 12:00 midnight, New York time, on February 9, 2021 (one minute after 11:59 P.M., New York time, on February 8, 2021), the Offer expired as scheduled and was not extended. Philips expects to complete the acquisition of BioTelemetry later today through a merger under Section 251(h) of the General Corporation Law of the State of Delaware.
Royal Philips: Philips completes the acquisition of BioTelemetry, Inc. February 9, 2021
Combination of Philips and BioTelemetry results in a global leader in patient care management solutions for the hospital and the home
Amsterdam, the Netherlands -
The
acquisitionof BioTelemetry is a strong fit with Philips cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions. Philips patient care management solutions for the hospital include real-time patient monitoring, therapeutic devices, telehealth and informatics. Moreover, Philips has an advanced and secure cloud-based Philips
HealthSuite digital platformoptimized for the delivery of health care across care settings.
Lilly Completes Acquisition of Prevail Therapeutics
News provided by
Share this article
Share this article
INDIANAPOLIS, Jan. 22, 2021 /PRNewswire/ Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality for drug discovery and development at Lilly, extending Lilly s research efforts through the creation of a gene therapy program that will be anchored by Prevail s portfolio of clinical-stage and preclinical neuroscience assets. We are pleased to complete the acquisition of Prevail and establish a gene therapy program at Lilly that has the potential to deliver transformative treatments for patients with neurodegenerative diseases such as Parkinson s, Gaucher and dementia, said Mark Mintun, M.D., vice president of pain and neurodegeneration research at Lilly.
Provided by PR Newswire
NII Holdings Provides Update On Dissolution Proceedings And Settlement With AT&T
NII Holdings Provides Update On Dissolution Proceedings And Settlement With AT&T
PR Newswire
RESTON, Va., Jan. 12, 2021
RESTON, Va., Jan. 12, 2021 /PRNewswire/ On January 12, 2021, NII Holdings, Inc. ( NII ) announced that it has reached agreement with AT&T Mobility Holdings B.V., New Cingular Wireless Services, Inc., AT&T Holdings Mexico, S. de R.L. de C.V., and AT&T Comunicaciones Digitales, S. de R.L. de C.V. (collectively, AT&T ) related to the amount of security needed to secure AT&T s contingent contractual claims in NII s dissolution proceedings (the Settlement ).